2016 BIO CEO & Investor Conference Buzz of BIO Winners Announced

Washington, D.C. (January 12, 2016) – The Biotechnology Innovation Organization (BIO) is pleased to announce the winners of the 2016 BIO CEO & Investor Conference Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. Taking place February 8-9, 2016 at the Waldorf Astoria Hotel in New York City, the 18^th Annual BIO CEO & Investor Conference will focus on investment opportunities for established and emerging publicly traded and select private biotech companies.

“The Buzz of BIO competition spotlights both private companies looking for their next round of financing as well as public companies looking to make new and valuable connections,” said Jim Greenwood, BIO President & CEO. “We are pleased to feature these cutting-edge companies as our Buzz of BIO winners and provide them an opportunity to meet potential new partners at the BIO CEO & Investor Conference.”

The Buzz of BIO at the BIO CEO & Investor Conference competition featured 20 nominees pulling in over 1,200 votes. The competition is sponsored by Tiberend Strategic Advisors, Inc. with support from BioCentury Publications.

The winners are:

Most Buzzworthy Private Company: Biothera Pharmaceutical, Inc.

Biothera Pharmaceutical, Inc. is an immune oncology company. Its lead investigational drug, Imprime PGG, triggers a coordinated anti-cancer immune response and works in combination with other cancer immunotherapy drugs.

Most Buzzworthy Public Company: StemCells, Inc.

StemCells, Inc. is currently engaged in clinical development of its proprietary HuCNS-SC® (purified human neural stem cells) platform technology to treat diseases of the human central nervous system (CNS).

Winners receive one complimentary registration to the BIO CEO & Investor Conference, a complimentary Company Presentation and promotion to industry leaders including a spotlight in BioCentury Extra.

Over 170 companies are expected to present at this year’s event. New presenters are continuously being added. For updates on the list of presenting companies, please visit here. If you are interested in becoming a presenter, please submit an application here. The typical audience for company presentations features public, institutional and private equity investors, research analysts, investment bankers and industry executives. 

To learn more about the BIO CEO & Investor Conference, including registration, program and partnering information, please visit here. Media registration is now open for qualified members of the press.

Upcoming BIO Events